Supports toxin elimination, nutrient absorption, brain, cardiovascular health, immunity, energy, antioxidant, reduces liver processing burden
GLP-1 receptor agonists modulate dopaminergic signaling by increasing dopamine--hydroxylase levels, reducing dopamine release, enhancing dopamine transporter expression, increasing dopamine turnover, and suppressing NAc projections, which attenuates phasic dopaminergic signaling and reduces consummatory behaviors (Eren-Yazicioglu et al., 2021)
22 The current proof-of-concept study was designed to evaluate whether (in)GSH is capable of augmenting CNS GSH concentrations, as measured by 1 H-MRS
Real-world examples: when B12 correction changes weight A common clinical pattern illustrates the point